DrugDashboards

Market view

peginterferon alfa-2a

2 marketed package NDCs · 1 active manufacturer

Most dispensed: 180 ug/mL · Injection, Solution · #1 vial, single-use/box / 1 ml in 1 vial, single-use

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $1070.90 per mL over the past year. A shortage here was resolved within the past year — markets usually stay tight for a while after.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$500.00$1000.00$1500.00Oct 2024Oct 202501companies actively selling

Latest · Oct 2025 — typical price $1070.90 · middle half $1070.90$1070.90 · full range $1070.90$1070.90 · 1 products · 1 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per mLSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for peginterferon alfa-2a, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • PegasysAug 28, 2026
    Resolvedby this manufacturer
    pharmaand GmbH (pharma&)'s Pegasys (Injection, 180 ug/.5 mL) is out of shortage1 company markets pegasys
  • PegasysAug 28, 2026
    Resolvedby this manufacturer
    pharmaand GmbH (pharma&)'s Pegasys (Injection, 180 ug/1 mL) is out of shortage1 company markets pegasys

Common questions

Is Peginterferon alfa-2a in shortage right now?
No. FDA does not currently list Peginterferon alfa-2a in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Peginterferon alfa-2a?
1 company has marketed Peginterferon alfa-2a in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • Shortage endedPegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4)Jan 24, 2025
  • Shortage endedPegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1)Jan 24, 2025

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.